<unk>  may spontaneously regress on reduction or cessation of immunosuppressant medication, and can also be treated with addition of anti-viral therapy. In some cases it will progress to non-Hodgkin's lymphoma and may be fatal. A phase 2 study of adoptively transferred EBV-specific T cells demonstrated high efficacy with minimal toxicity.
Post-transplant lymphoproliferative disorder
AIDS-related lymphoma
Transfusion-associated graft-versus-host disease
Thymoma-associated multiorgan autoimmunity
Splenic marginal zone lymphoma
Graft-versus-host disease
Diffuse infiltrative lymphocytosis syndrome
Immune reconstitution inflammatory syndrome